Conference Overview

The North American College of Pharmaceutical Technology (NACPT) presented its 1st educational cannabis conference on December 7th and 8th, 2018 at the McLeod Auditorium, 1 King’s College Circle, Toronto, Ontario, M5S 1A8.

NACPT is  a leading Cannabis / Marijuana training provider among few Cannabis Schools, and Marijuana Institutes / Marijuana colleges in North America.

 NACPT brought together a highly qualified panel which included healthcare professionals, scientists and respected industry leaders to share their expertise in various sectors of the cannabis industry.



The conference featured a multi-faceted overview of the process ranging from the production process to assessing patient’s eligibility for medical cannabis and determining which product would be ideal in treating specific medical conditions. Educators and professionals were made aware of cutting-edge research and information to facilitate public and patient education, and enable them to make decisions on cannabis use.

The two-day conference provided attendees with a clear understanding of up-to-date medical  cannabis industry legal regulations, patient care perspectives, clinical studies, career development and other areas of interest.

NACPT’s unprecedented initiative showcased industry leaders, healthcare professionals and exhibitors in one forum to share valuable insights. Furthermore, this event promoted an unparalleled networking platform for those pursuing medical cannabis literacy.

MEdical Cannabis Conference

Conference Outcome

At the end of the conference, NACPT Pharma College conducted a survey from attendees, speakers, exhibitors and media publications.

Overall, the conference had a positive constructive feedback with the rating of 5 out 5.


Attendees had a in-depth learning opportunity with highly qualified speakers’.

With wide range of medical cannabis educational presentations and participation in panel discussions on both days, attendees were able to have their questions responded.



Questions like:

– What are the prospects of starting cannabis business in Canada?

– What are the legal realities related to cannabis sectors?

– How to deal with medical or recreational cannabis at work place,

policy making when dealing with Cannabis products and employees?

– How to proceed with the licensing process with Health Canada?

– How to develop a product in cannabis industry?

– What is the importance of clinical studies and validation?

– How do we consult patients and consumers?

And much more …

To have a more in depth understanding of all topics covered in the conference, please have a look at NACPT’s Professional Serie of Medical Cannabis Workshops. Click HERE.


Dr. Hyder A. Khoja

Dr. Khoja; is an elocutionist, philosopher, a visionary entrepreneur & a business savvy. He has had a distinguished professional career, within the high technology realms with strong adaptive ability in leading diverse regulatory programs combined with functional expertise in science and policy domains. His industrial experience spans from advising, innovating & developing cutting-edge projects. He led multidisciplinary teams consisting of Professionals-Engineers, Scientists, and Planners. While working with them; he built a foundation of strong cross-functional skills including Research & Business Development. He has been instrumental in advising to the board for several private and publicly traded start-up companies. Since then he has been a liaison for many educational and industrial cooperative programs.
In 2010, he founded ‘LeoFric Consultants, Inc.’ which helped design highly targeted knowledge-based solutions to address the global client’s challenges. Early in 2014, he Co-Founded InMed Pharmaceuticals and directed Botanical Drug development for their pre-clinical stage R&D, developing novel therapies into the extensive pharmacological application through cannabinoids. In 2015, he joined Affinor, Inc as a VP of Research and innovations and sat on the board of governors. He now serves as a CSO for NASH Pharmaceuticals, Inc and Oceanix Biotech; specializes in developing novel therapies through R&D into the extensive pharmacology from marine biomass and to develop GMP (APIs).
Dr. Khoja earned his PhD., with honors in Cellular & Molecular Biology’ from a French Ivy league: INP-ENSAT. He had his postdoctoral training from the Michigan State University a US land grant university. Soon after, he was appointed as a Research Faculty for Virginia-Tech, University of Wyoming & Texas-Tech University-Health Science Center. His breakthrough research work on “Algae 4 Fuel” was recognized by the US-DOE (Department of Energy) and raised $25 million. His scientific works have been published in over 30 peer-reviewed journals. In 2011, his work was honored by the United Nation’s-FAO. He is an elocutionist and has a command over 12 international languages.

Kathleen Hedley

Kathleen Hedley is a former director of Health Canada and Environmental Approvals at Ontario Ministry of the Environment and Climate Change, having spent over 30 years in the federal and provincial governments in a variety of regulatory and policy positions. Currently, she is the Vice President of a startup cannabis company called Green Amber Canada. As a Director with Health Canada, she worked briefly in the Office of Medical Marijuana. She has an M.Sc. in Atmospheric Chemistry from York University, Meteorology from McGill University and Bachelor of Applied Science from University of Western Ontario.

Pauline Garrard is an advocate of Medical Marijuana and a patient since 2014. After suffering from debilitating neck pain for years, she was diagnosed with severe arthritis. She became discouraged after years of taking many different types of pain medication, because of unwanted and dangerous side effects. She finally went to her doctor to ask for a prescription for Medical Marijuana. After being turned down by her own doctor and a specialist, she went on long a journey to navigate the MMAR system (which was the system run by Health Canada before April 2014). Two years later she was finally able to obtain a license to possess and use Medical Marijuana under the new MMPR rules. After she had her license and told people with serious health concerns about it, they all wanted help to navigate the system.

That is when Canna Relief Consulting Canada Inc. was born in August 2014. The company started as a resource for patients to get assistance to access the Health Canada system by getting a prescription from a doctor. Pauline has taken many educational training including CCIC and the International Pharmaceutical Academy. She has personally educated over 1,000 patients about medical cannabis. She holds a diploma in Sales and Marketing. Canna Relief provides up to date information which comes from their studying research and from feedback from existing patients. Their goal is to be experts in the options available for the delivery of Medical Marijuana for patients and to counsel patients in a compassionate and non-judgemental environment. In April 2017 the company opened their first Canna Relief storefront location in Mississauga, Ontario. The store sells natural hemp and other healthy products such as pain creams, probiotics, and vaporizers. The store is also a resource for the public to learn about medical marijuana and the options available to them. Pauline is also working to promote and market the CannaRelief drink which is a CBD drink made from hemp. It is the first THC antidote on the market which reduces anxiety, nausea, and other negative symptoms which can occur from accidental THC overuse. It is being sold all over the USA and worldwide, and will be sold in pharmacies and other retail outlets in Canada when recreational cannabis legalization occurs in 2018

Jonathan has been a cannabis activist for many years and has gained extensive knowledge regarding effective, efficient and safe cultivation of cannabis. He has also been involved with other aspects of the industry, including safe consumption and storage of cannabis. As an activist, Jonathan has a diverse network of stakeholders across Canada who are also active in the industry. His experience working in a regulatory environment and Cannabis related experience are key when navigating through process and approvals.

Rathi Param is the president/founder of the North American College of Pharmaceutical Technology (NACPT) and ValidationTech Inc. She is also acting as the director of International Medical Cannabis Association (IMCA). Rathi earned her B.Sc. in Chemistry from University Ottawa, MBA in Technology from University of Phoenix and Post Graduate Pharmaceutical QA & QC Certification from SRN Institute. She is an innovative and creative leader with more than fifteen years of hands-on experience in many scientific industries (medical cannabis, medical devices, environmental, food, pharmaceutical and bio-pharmaceutical), complemented with ten years of training/teaching experience. She possesses extensive expertise and knowledge of Quality Control, Quality Assurance, Validation, Technology Transfer, Manufacturing Technology, Process Improvements, Auditing, and Inspection. Rathi is also a QAP consultant for Green Amber Canada (Cannabis Producer).  In addition, Rathi has been assisting medical cannabis companies in regards to the application process to become a Licensed Producer of Cannabis for Medical Purposes through Health Canada.

 In the past 15+ years, Rathi has held strategic management roles in major Canadian name brand/generic pharmaceutical companies. Validation Scientist at Patheon Inc., Validation Services Manager at Sanofi Pasteur Limited, Toronto., Validation Specialist at CibaVision, Toronto., and Validation Quality Engineer (Consultant) at iPOC, Toronto, Quality Assurance Person in charge at Green Amber Canada, Toronto to name a few. Her interest in helping graduates to commence their careers in the pharmaceutical and related industries was the motivation to launch NACPT and Validation Tech, to provide hands-on training and create a platform to direct the pathway to successful recruitment by the pharmaceutical and related companies.

Gavin Clark has a deep understanding of cannabis and the developing industry in Canada as well as internationally. This includes the many beneficial properties of cannabis chemistry, their medical applications as well the legal framework regulating it in Canada.
A graduate of the University of Western Ontario in Political Science, Gavin has been a medical cannabis patient for more than twenty-five years and has been researching various aspects of medical cannabis use for much of that time. As Managing Director of Delta Eight Pharmaceuticals, Gavin is involved in research and development work in medical and recreational cannabis.  Gavin currently works as an advisor to cannabis-based businesses including Newstrike and Up Cannabis.

Karim Meghji Pharmaceutical College

Karim Meghji is a well-seasoned senior scientist with 25 years work experience in pharmaceutical, biopharmaceutical, CRO/CMO and CDMO companies. He acquired his MSc. in Biology from the University of Waterloo where he conducted research in microbial biotechnology and wrote a thesis on production, purification, and characterization of extracellular carboxylesterases from B. subtilis.  Prior to joining North American College of Pharmaceutical Technology (NACPT), Karim worked as a senior scientist in a CDMO and generics company called DPT Labs, in San Antonio, Texas (now acquired by Mylan N.V.), that specialized in topical dermatologic products. Karim has also worked for companies like QLT Inc. in Vancouver that developed the blockbuster photodynamic therapy drug Visudyne for wet age-related macular degeneration and worked as a research associate and safety officer for a leading CRO/CMO company formerly called Northern Lipids, Inc (now Evonik Transferra Nanosciences) in Vancouver, specializing in development and manufacture of complex drug delivery systems using lipid nanoparticle science. In these companies, Karim was responsible for optimizing, developing and validating HPLC and GC methods for analysis of peptides, cytotoxics, small molecules, siRNA and dsRNA in liquid, semi-solid, aerosol foam and liposomal drug formulations. In his role as CMC Manager in a virtual biotechnology company formerly called Protox Therapeutics Inc (acquired by Sophiris Bio Inc) in Vancouver, Karim oversaw and managed all chemistry, manufacturing and control aspects of the company’s pipeline by successfully working with third-party contractors.

AKM Abdul Hai Pharmaceutical

Dr. AKM Abdul Hai has many years of experience as a Product Development Scientist involving API Synthesis, Analytical Method, and Formulation Development.  His extensive knowledge of processes of Pharmaceutical and Biopharmaceutical drug products supported his career in Canada and abroad. To name a few, he has been working as a Chief Scientist at Molesci & Matesci  Inc, Scarborough and worked as Chief Scientific Officer with CMI Cosmetic, Toronto. Dr. Hai completed PhD from Okayama University, Japan in the field of Beta-Lactam Antibiotic Chemistry and his work is published in high level research journal and acquired specialization in Organo-copper Chemistry from Chalmers University of Technology, Sweden.  Dr Hai also did Post-doctoral research at the Department of Forest Biomaterials, North Carolina State University, USA.  He carried out  Research on Ionic Liquid Synthesis ant its application to Plant Derived Bio-mass conversation to small molecules of commercial application.  Dr Hai was a Senior Chemist with Toronto Research Chemicals Inc, Toronto and worked on the Synthesis of Organic Complex molecules for Biomedical Research. Dr. AKM is heavily involved in Cannabis oil extraction processes and cannabinoids based product  Formulation and Analytical development.  He also obtained Post Graduate Diploma in Industrial Pharmaceutical and Biopharmaceutical Modern Technology.

Jay Carnahan has been licensed by Health Canada since 1997 on an array of activities including growing, processing, distribution of different cannabis components. He is an expert in certified organic cannabis oil extraction and meeting ACMPR concentration and labeling requirements. Jay has been actively involved in producing and testing cannabis oil derivatives for CBD, CBDA, THC, & THCA.   His Company Tresvertol Inc. is a large-scale industrial processor of craft cannabis products.

Dr Danial Schecter - Canadian Cannabinoid Medical ClinicDr Danial Schecter is the co-founder and medical director of the Canadian Cannabinoid Medical Clinic (CMClinic), the first and largest referral only clinic network in Canada specializing in cannabinoid medicine.  He is a practicing family physician who has trained dozens of physicians in the field and has lectured at over a hundred events internationally. He spearheaded the creation of the Patient Handbook on Medical Cannabis used by many Canadian physicians as a patient education tool and has evaluated thousands of patients to decide if cannabinoid medicines are appropriate for them.

DR. Brais Medical Cannabis Sanuvox TechnologiesNormand Brais holds a mechanical engineering degree, a Master of Applied Sciences, and a PhD in Nuclear Engineering from
Polytechnique of Montreal. He was appointed Professor at the Energy Engineering Institute after he graduated. He has founded several technological companies in various fields such as atmospheric pollution of stationary combustion equipment, biomass combustion, water treatment, photonics, and air/surface UV disinfection. In 1995 he founded Sanuvox Technologies, which is now a worldwide technological leader in UV disinfection of air and surfaces for hospitals, office buildings, laboratories, and greenhouses.

Omar Khan Medical CannabisOmar has more than 15 years of experience working on issues of public policy, stakeholder management, and communications. He brings with him a deep understanding of the inner workings of government and politics having spent over a decade working at the highest levels of the Ontario government as well as federal and provincial election campaigns. With a diverse policy background across healthcare, economics, regulatory affairs, and labour relations, Omar has a proven track record developing complex policy proposals, building stakeholder coalitions and leading communications plans. A seasoned political and public policy professional, Omar brings focused experience in strategy development for effective public affairs and crisis communications.

Most recently, Omar served as Chief of Staff to the Ontario Minister of Health and Long-Term Care where he was responsible for, among other things, providing insights and counsel on emerging issues, strategic decisions and policy development to the Minister, Premier’s Office and other Cabinet members.

Omar has also worked as Chief of Staff at the Office of the Minister of Economic Development, Trade and Employment, and at the Office of the Minister of Government Services. He has been Senior Policy and Stakeholder Relations Advisor with the Offices of the Attorney General of Ontario, the Minister of Training, Colleges and Universities and the Minister of Labour.

Omar holds a bachelors degree in political science from the University of Western Ontario.

Omar has is passionate about community service.  He serves on the board of directors for War Child Canada, an organization dedicated to protecting children in war zones and is an active member of Civic Actions Escalator advisory board which works to enhance job opportunities for youth facing barriers to employment.

Vijay Sappani, is a co-founder and Chief Strategy Officer of TerraAscend Copr., a publicly listed diversified Canadian Cannabis Company. Vijay has held senior positions with Natco Pharma (Canada) Inc. and Biovail. He also served as Senior Special Assistant to the Ontario Minister of Health and Long-term Care and was a member of the board of the ministry’s Pharmacy Council. Vijay has a B.Pharm and post-graduate degree in Marketing.

Conference material is available for purchase, please email us for more information at

Follow us!